803550751	803550751	CD	B-NP	O
|	|	NN	I-NP	O
SDMH	SDMH	NN	I-NP	O
|	|	NN	I-NP	O
23447128	23447128	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6489156	6489156	CD	B-NP	O
|	|	CC	I-NP	O
7/30/2003	7/30/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/29/2003	11/29/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/3/2003	11/3/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
NORAT	NORAT	NNP	B-NP	O
,	,	,	O	O
EUGENIO	EUGENIO	NNP	B-NP	O
559-09-85-9	559-09-85-9	CD	I-NP	O
Er	Er	NNP	I-NP	B-protein
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/12/03	6/12/03	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
EVANOSKI	EVANOSKI	NNP	B-NP	O
,	,	,	O	O
CLAY	CLAY	NNP	B-NP	O
CRUZ	CRUZ	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/8/03	1/8/03	CD	B-NP	O
by	by	IN	B-PP	O
FISCELLA	FISCELLA	NNP	B-NP	O
,	,	,	O	O
JAROD	JAROD	NNP	B-NP	O
P	P	NNP	I-NP	O
BRIAN	BRIAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
12	12	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
27768820	27768820	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/20/03	10/20/03	CD	B-NP	O
by	by	IN	B-PP	O
MIVILLE	MIVILLE	NNP	B-NP	O
,	,	,	O	O
ISAAC	ISAAC	NNP	B-NP	O
CHASE	CHASE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
98094507	98094507	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/03	10/10/03	CD	B-NP	O
by	by	IN	B-PP	O
BEALLE	BEALLE	NNP	B-NP	O
,	,	,	O	O
ODELL	ODELL	NNP	B-NP	O
MICHAL	MICHAL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
8	8	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
22984075	22984075	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/03	10/10/03	CD	B-NP	O
by	by	IN	B-PP	O
TAETZSCH	TAETZSCH	NN	B-NP	O
,	,	,	O	O
ERIK	ERIK	NNP	B-NP	B-protein
COLTON	COLTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
02061589	02061589	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/22	2/22	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/15	9/15	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/12/03	6/12/03	CD	B-NP	O
by	by	IN	B-PP	O
BROCKS	BROCKS	NNP	B-NP	O
,	,	,	O	O
ALONZO	ALONZO	NNP	B-NP	O
A	A	NNP	I-NP	O
MILO	MILO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/12/03	6/12/03	CD	B-NP	O
by	by	IN	B-PP	O
ACTON	ACTON	NNP	B-NP	O
,	,	,	O	O
MARK	MARK	NNP	B-NP	O
MAXWELL	MAXWELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

EUCERIN	EUCERIN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
PETROLATUM	PETROLATUM	NN	I-NP	O
HYDROPHILIC	HYDROPHILIC	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/7	9/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
use	use	VB	I-VP	O
moisturizing	moisturize	VBG	I-VP	O
lotion	lotion	NN	B-NP	O
of	of	IN	B-PP	O
choice	choice	NN	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12	12	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/03	1/8/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/20/03	10/20/03	CD	B-NP	O
by	by	IN	B-PP	O
TALIAFERRO	TALIAFERRO	NN	B-NP	O
,	,	,	O	O
WILMER	WILMER	NNP	B-NP	O
CLAUDE	CLAUDE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/03	10/10/03	CD	B-NP	O
by	by	IN	B-PP	O
SALWAY	SALWAY	NNP	B-NP	O
,	,	,	O	O
JACKIE	JACKIE	NNP	B-NP	O
MARCOS	MARCOS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/03	10/10/03	CD	B-NP	O
by	by	IN	B-PP	O
WEELER	WEELER	NNP	B-NP	O
,	,	,	O	O
ANTOINE	ANTOINE	NNP	B-NP	O
JUSTIN	JUSTIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/22	2/22	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
CELEXA	CELEXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Erik	Erik	NNP	I-NP	O
Packen	Packen	NNP	I-NP	O
,	,	,	O	O
Redou	Redou	NNP	B-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
Oklahoma	Oklahoma	NNP	B-NP	O
,	,	,	O	O
135-618-4242	135-618-4242	CD	B-NP	O
,	,	,	I-NP	O
10/27/03	10/27/03	CD	I-NP	O
,	,	,	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Laboratory	Laboratory	NN	B-NP	O
draw	draw	NN	I-NP	O
for	for	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Check	Check	NNP	I-NP	O
,	,	,	O	O
Outpatient	Outpatient	NNP	B-NP	O
Laboratory	Laboratory	NNP	I-NP	O
,	,	,	O	O
Mont	Mont	NNP	B-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Hollis	Hollis	NNP	I-NP	O
Chesher	Chesher	NNP	I-NP	O
,	,	,	O	O
Psychiatry	Psychiatry	NNP	B-NP	O
,	,	,	O	O
Rill	Rill	NNP	B-NP	O
Jack	Jack	NNP	I-NP	O
Cifran	Cifran	NNP	I-NP	O
,	,	,	O	O
780-184-2650	780-184-2650	CD	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
7/30/03	7/30/03	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Mudgett	Mudgett	NNP	I-NP	O
,	,	,	O	O
Office	Office	NNP	B-NP	O
with	with	IN	B-PP	O
call	call	NN	B-NP	O
or	or	CC	I-NP	O
mail	mail	NN	I-NP	O
appointment	appointment	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
670-618-2282	670-618-2282	CD	B-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
11/24/03	11/24/03	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7daysorasdirected	7daysorasdirecte	VBN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
107-568-5779	107-568-5779	CD	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
dyspnea	dyspnea	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
appendectomy	appendectomy	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
psych-anxiety/depression	psych-anxiety/depression	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
emboli	embolus	NNS	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
conjunctivitis	conjunctivitis	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
now	now	RB	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
after	after	IN	B-SBAR	O
admitted	admit	VBN	B-NP	O
dietary	dietary	JJ	I-NP	O
indiscretion	indiscretion	NN	I-NP	O
.	.	.	O	O

Reports	Report	NNS	B-NP	O
cough	cough	VBP	B-VP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
99.5	99.5	CD	I-NP	O
HR	HR	NN	I-NP	O
100	100	CD	B-NP	O
's	's	POS	B-NP	O
RR	RR	NN	I-NP	O
22	22	CD	I-NP	O
BP	BP	NN	I-NP	O
150/79	150/79	CD	B-NP	O
88	88	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
decreased	decrease	VBN	B-NP	O
air	air	NN	I-NP	O
exchange	exchange	NN	I-NP	O
with	with	IN	B-PP	O
end-expiratory	end-expiratory	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

COR	COR	NN	B-NP	O
:	:	:	O	O
irreg	irreg	NN	B-NP	O
irreg	irreg	NN	I-NP	O
nl	nl	NN	I-NP	O
S1S2	S1S2	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

LE	LE	NN	B-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bil	bil	NN	I-NP	O
to	to	TO	B-PP	O
shins	shin	NNS	B-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
Troponin	Troponin	NN	B-NP	O
<	<	SYM	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
WBC	WBC	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

ECG	ECG	NN	B-NP	O
:	:	:	O	O
Afib	Afib	NN	B-NP	O
without	without	IN	B-PP	O
new	new	JJ	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
with	with	IN	B-PP	O
episodic	episodic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
admitted	admit	VBD	B-VP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
dietary	dietary	JJ	I-NP	O
indiscretions	indiscretion	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
medication	medication	NN	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
ECG	ECG	NN	I-NP	O
and	and	CC	I-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
dyspnea/chest	dyspnea/ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
digoxin	digoxin	NN	B-NP	O
loaded	loaded	JJ	B-ADJP	O
and	and	CC	O	O
aggressively	aggressively	RB	B-VP	O
diuresed	diurese	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
140.7	140.7	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
was	be	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
by	by	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation/history	fibrillation/history	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.9	1.9	CD	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
discharge	discharge	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
lovenox	lovenox	NN	I-NP	O
bridge	bridge	NN	I-NP	O
but	but	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	B-PP	O
follow-up	follow-up	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
check	check	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Youmans	Youmans	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Elke	Elke	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
his	his	PRP$	B-NP	O
new	new	JJ	I-NP	O
PCP	PCP	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
PSYCH	PSYCH	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
TM	TM	NN	I-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
nicotene	nicotene	NN	I-NP	O
addiction	addiction	NN	I-NP	O
and	and	CC	O	O
made	make	VBN	B-VP	O
referrals	referral	NNS	B-NP	O
for	for	IN	B-SBAR	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
smoking	smoking	NN	I-NP	O
cessation	cessation	NN	I-NP	O
program	program	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Johour	Johour	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

Pyschiatry	Pyschiatry	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
resuming	resume	VBG	I-VP	O
celexa	celexa	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
a	a	DT	B-NP	O
psychiatric	psychiatric	JJ	I-NP	O
social	social	JJ	I-NP	O
worker	worker	NN	I-NP	O
for	for	IN	B-PP	O
counseling	counseling	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
develop	develop	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hollaway	Hollaway	NNP	I-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Record	Record	NNP	B-NP	O
daily	daily	JJ	I-NP	O
am	am	NN	I-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
bring	bring	VB	B-VP	O
record	record	NN	B-NP	O
to	to	TO	B-PP	O
doctor	doctor	NN	B-NP	O
's	's	POS	B-NP	O
visits	visit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
weight	weight	NN	B-NP	O
changes	change	NNS	I-NP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
lbs	lb	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Bonadurer	Bonadurer	NNP	I-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Must	Must	NNP	B-NP	O
go	go	VBP	B-VP	O
to	to	TO	B-PP	O
Ta	Ta	NNP	B-NP	O
Fay	Fay	NNP	I-NP	O
Ho	Ho	NNP	I-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
lab	lab	NN	B-NP	O
draw	draw	NN	I-NP	O
on	on	IN	B-PP	O
Thurday	Thurday	NNP	B-NP	O
,	,	,	O	O
March	March	NNP	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
clinic	clinic	NN	I-NP	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
psychiatry	psychiatry	NN	I-NP	B-protein
social	social	JJ	I-NP	I-protein
worker	worker	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
YANAGAWA	YANAGAWA	NNP	B-NP	O
,	,	,	O	O
NICOLAS	NICOLAS	NNP	B-NP	O
BRIAN	BRIAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
YD47	YD47	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/12/03	6/12/03	CD	I-NP	O
@	@	SYM	O	O
01	01	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

